Clinical Significance of Continuable Treatment with Nintedanib Over 12 Months for Idiopathic Pulmonary Fibrosis in a Real-World Setting

Clinical Significance of Continuable Treatment with Nintedanib Over 12 Months for Idiopathic Pulmonary Fibrosis in a Real-World Setting

Motoyasu Kato,1 Shinichi Sasaki,1,2 Misa Tateyama,1 Yuta Arai,1 Hiroaki Motomura,1 Issei Sumiyoshi,1 Yusuke Ochi,1 Junko Watanabe,1 Hiroaki Ihara,1 Shinsaku Togo,1 Kazuhisa Takahashi1 1Department of Respiratory Medicine, Juntendo University Graduate School of Medicine, Tokyo, Japan; 2Department of R...

Full description

Bibliographic Details
Main Authors: Kato M, Sasaki S, Tateyama M, Arai Y, Motomura H, Sumiyoshi I, Ochi Y, Watanabe J, Ihara H, Togo S, Takahashi K
Format: Article
Language:English
Published: Dove Medical Press 2021-01-01
Series:Drug Design, Development and Therapy
Subjects:
idiopathic pulmonary fibrosis
nintedanib
real-world setting
performance status
nausea
Online Access:https://www.dovepress.com/clinical-significance-of-continuable-treatment-with-nintedanib-over-12-peer-reviewed-article-DDDT

Internet

https://www.dovepress.com/clinical-significance-of-continuable-treatment-with-nintedanib-over-12-peer-reviewed-article-DDDT

Similar Items